Equities

J B Chemicals and Pharmaceuticals Ltd

JBCHEPHARM:NSI

J B Chemicals and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,840.70
  • Today's Change-19.30 / -1.04%
  • Shares traded122.89k
  • 1 Year change+25.22%
  • Beta0.1705
Data delayed at least 15 minutes, as of Nov 08 2024 10:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4,5962,692578
Total Receivables, Net8,6027,9487,557
Total Inventory5,1384,4414,411
Prepaid expenses163167120
Other current assets, total343283
Total current assets18,53315,28012,749
Property, plant & equipment, net6,3495,7645,668
Goodwill, net575575575
Intangibles, net13,88513,2236,714
Long term investments285274175
Note receivable - long term192299120
Other long term assets5250--
Total assets39,94135,53926,074
LIABILITIES
Accounts payable3,5632,3862,245
Accrued expenses00.260.06
Notes payable/short-term debt1532800
Current portion long-term debt/capital leases3,2901,459339
Other current liabilities, total1,6751,4191,253
Total current liabilities8,6825,5443,837
Total long term debt3333,985206
Total debt3,7775,724546
Deferred income tax1,4921,028476
Minority interest0045
Other liabilities, total201177169
Total liabilities10,70810,7354,733
SHAREHOLDERS EQUITY
Common stock155155155
Additional paid-in capital1,134697508
Retained earnings (accumulated deficit)28,08923,98820,582
Treasury stock - common------
Unrealized gain (loss)3.493.493.49
Other equity, total(149)(40)94
Total equity29,23324,80421,341
Total liabilities & shareholders' equity39,94135,53926,074
Total common shares outstanding155155155
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.